These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35994781)

  • 1. Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach.
    Advani D; Kumar P
    Neuropeptides; 2022 Dec; 96():102283. PubMed ID: 35994781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
    Bisht I; Ambasta RK; Kumar P
    Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge graph analytics platform with LINCS and IDG for Parkinson's disease target illumination.
    Yang JJ; Gessner CR; Duerksen JL; Biber D; Binder JL; Ozturk M; Foote B; McEntire R; Stirling K; Ding Y; Wild DJ
    BMC Bioinformatics; 2022 Jan; 23(1):37. PubMed ID: 35021991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic and Genetic Associations between Alzheimer's Disease, Parkinson's Disease, and Cancer.
    Forés-Martos J; Boullosa C; Rodrigo-Domínguez D; Sánchez-Valle J; Suay-García B; Climent J; Falcó A; Valencia A; Puig-Butillé JA; Puig S; Tabarés-Seisdedos R
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.
    Vargas DM; De Bastiani MA; Parsons RB; Klamt F
    Mol Neurobiol; 2021 Apr; 58(4):1517-1534. PubMed ID: 33211252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREB1
    Gupta R; Kumar P
    ACS Omega; 2021 Dec; 6(51):35780-35798. PubMed ID: 34984308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Parkinson's Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network.
    Liu J; Peng D; Li J; Dai Z; Zou X; Li Z
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35897954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Drug Repurposing for Parkinson's Disease.
    Chen X; Gumina G; Virga KG
    Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bidirectional drug repositioning approach for Parkinson's disease through network-based inference.
    Rakshit H; Chatterjee P; Roy D
    Biochem Biophys Res Commun; 2015 Feb; 457(3):280-7. PubMed ID: 25576361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression.
    Cong Y; Shintani M; Imanari F; Osada N; Endo T
    OMICS; 2022 Jun; 26(6):339-347. PubMed ID: 35666246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.
    Redenšek S; Dolžan V; Kunej T
    OMICS; 2018 Jan; 22(1):1-16. PubMed ID: 29356624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease.
    Chen Y; Cai X; Xu R
    AMIA Annu Symp Proc; 2015; 2015():1851-60. PubMed ID: 26958284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Repurposing in Parkinson's Disease.
    Athauda D; Foltynie T
    CNS Drugs; 2018 Aug; 32(8):747-761. PubMed ID: 30066310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
    Su L; Wang C; Zheng C; Wei H; Song X
    BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.
    Mokou M; Narayanasamy S; Stroggilos R; Balaur IA; Vlahou A; Mischak H; Frantzi M
    Methods Mol Biol; 2023; 2684():59-99. PubMed ID: 37410228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing strategies of relevance for Parkinson's disease.
    Fletcher EJR; Kaminski T; Williams G; Duty S
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00841. PubMed ID: 34309236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with Parkinson's disorder.
    Zhao H; Zhang Q; Chen H; Rahman MR; Faruquee HM
    Saudi J Biol Sci; 2021 Dec; 28(12):6939-6945. PubMed ID: 34366686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching the basics of repurposing mitochondria-targeted drugs: From Parkinson's disease to cancer and back to Parkinson's disease.
    Kalyanaraman B
    Redox Biol; 2020 Sep; 36():101665. PubMed ID: 32795938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
    Kim I; Choi S; Kim S
    BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.